Wastewater treatment system

Information

  • Patent Grant
  • 7718057
  • Patent Number
    7,718,057
  • Date Filed
    Thursday, September 18, 2008
    16 years ago
  • Date Issued
    Tuesday, May 18, 2010
    14 years ago
Abstract
This invention is directed to a wastewater treatment system having a fluidizable media carrying anoxic bacteria in a first treatment zone and a filter membrane positioned in a second treatment zone. A wastewater is contacted with the fluidizable media and further contacted with air and a filter membrane.
Description
BACKGROUND OF INVENTION

1. Field of Invention


The present invention relates to a system and method for treating wastewater, and more particularly to a wastewater treatment system and method utilizing a membrane bioreactor.


2. Discussion of Related Art


The importance of membrane for treatment of waste water is growing rapidly. With the arrival of submerged membrane processes where membrane modules are immersed in a large feed tank and filtrate is collected typically through suction applied to the filtrate side of the membrane, membrane bioreactors (MBRs) combining biological and physical processes in one stage promise to be more compact, efficient and economic. Membrane bioreactors are typically sized to accommodate community and large-scale sewage treatment, i.e. 160,000 gpd, and 20-40 mgd and more. These large-scale wastewater treatment systems are commonly designed to operate while attended, have numerous controls, and typically require chemical addition. A need remains for a simple, robust small scale wastewater treatment systems designed for relatively unattended use, requiring only periodic maintenance.


SUMMARY OF INVENTION

In accordance with one or more embodiments, the invention relates to a system and method of treating wastewater.


In one embodiment, a wastewater treatment system includes a first treatment zone fluidly connected to a second treatment zone. A fluidizable media carrying anoxic bacteria is positioned in the first treatment zone, and a membrane module comprising a filter membrane is positioned in the second treatment zone. The wastewater treatment system may also comprise an oxygen depleting zone.


Another embodiment is directed to a method of treating wastewater includes contacting a wastewater with an anoxic bacteria immobilized on a fluidized media to produce a first water product. The first water product is contacted with air to from a second water product which is passed through a filter membrane to produce a concentrated mixed liquor and a filtrate.


Another embodiment is directed to a method of treating a wastewater including passing a wastewater through a fluidized bed carrying anoxic bacteria to produce a first treated wastewater. A portion of the first treated wastewater is passed through a filter membrane to produce a concentrated mixed liquor and a filtrate, which is discharged.





BRIEF DESCRIPTION OF DRAWINGS

The accompanying drawings are not intended to be drawn to scale. In the drawings, each identical or nearly identical component that is illustrated in various figures is represented by a like numeral. For purposes of clarity, not every component may be labeled in every drawing. In the drawings:



FIG. 1 illustrates a system in accordance with one or more embodiments of the invention; and



FIG. 2 is a flow chart illustrating a process in accordance with one or more embodiments of the invention.





DETAILED DESCRIPTION

This invention is not limited in its application to the details of construction and the arrangement of components set forth in the following description or illustrated in the drawings. The invention is capable of other embodiments and of being practiced or of being carried out in various ways. Also, the phraseology and terminology used herein is for the purpose of description and should not be regarded as limiting. The use of “including,” “comprising,” or “having,” “containing,” “involving,” and variations thereof herein, is meant to encompass the items listed thereafter and equivalents thereof as well as additional items.


This invention is directed to wastewater treatment systems utilizing membrane bioreactors designed to treat wastewater flow of about 10,000 gpd or less. In one embodiment the wastewater treatment system is designed to treat wastewater flow of about 5,000 gpd. One or more embodiments are directed to a fluidized bed containing bacterial micro-organisms in conjunction with an MBR. Some aspects relative to one or more embodiments also include utilizing an oxygen depletion zone in conjunction with the MBR. “Wastewater,” as used herein, defines a stream of waste from a residential or community source, having pollutants of biodegradable material, inorganic or organic compounds capable of being decomposed by bacteria, flowing into the wastewater treatment system. As used herein, a “wastewater treatment system” is a system, typically a biological treatment system, having a biomass population of bacterial micro-organisms of a diversity of types of bacteria, used to digest biodegradable material. Notably, the biomass requires an environment that provides the proper conditions for growth.


One embodiment of the present invention includes bioreactor having one or more treatment zones. As used herein, the phrase “treatment zone” is used to denote an individual treatment region. Individual treatment regions may be housed in a single vessel with one or more compartments. Alternatively, individual treatment regions may be housed in separate vessels, wherein a different treatment is carried out in separate vessels. The treatment zone, i.e. the vessel or compartment, may be sized and shaped according to a desired application and volume of wastewater to be treated.


The wastewater treatment system may comprise a fluidizable media housed in a first treatment zone. The fluidizable media may comprise biomass carriers designed to immobilize anoxic organisms. The biomass carriers may be formed of any material suitable to support organisms and to remain fluidized under operating conditions. In one embodiment, the fluidizable media has a specific gravity substantially the same as that of water. In another embodiment the fluidizable media has a surface area adequate to allow denitrifying bacteria to grow, which may enhance the efficiency of the anoxic reaction to remove nitrogen.


Any volume of fluidizable media may be utilized within the first treatment zone for a particular purpose. For example, a maximum volume of fluidized media may be used to substantially fill the first treatment zone, or a lesser volume of fluidized material may be used to fill a portion of the first treatment zone. Without being bound by any is particular theory, passing wastewater through denitrifying bacteria immobilized on the fluidizable media may increase the efficiency of the denitrification process.


The first treatment zone may also comprise means for maintaining the fluidized media within the first treatment zone during operation. For example, a baffle, weir, screen or perforated plate may be used to maintain the fluidizable media within the first treatment zone. Alternatively, the fluidizable media may be prevented from exiting the first treatment zone by establishing fluid counter currents during operation so that the fluidizable material remains appropriately suspended. In one embodiment, a screen or perforated plate is positioned across an entire cross sectional area of a vessel or compartment forming the first treatment zone to maintain the fluidizable media within the first treatment zone. The screen or perforated plate may also assist in providing a substantially uniform density of fluidizable media over the entire cross sectional area of the first treatment zone. One or more screens or perforated plates may be positioned within the first treatment zone to establish one or more fluidized bed regions. For example, one screen may be positioned at or near the top of the first treatment zone to contain a first fluidizable media region, and a second screen may be positioned below the first screen to contain a second fluidizable media region. The fluidizable media may, but need not be the same in the separate regions. Similarly, the fluidizable media may support the same or different anoxic organisms in the separate regions.


According to one embodiment of the invention, one or more porous or permeable membranes may be positioned in a second treatment zone. The membrane may have any configuration suitable for a particular purpose, such as sheet or hollow tube. The membrane may be formed of any material (natural or synthetic) suitable for a particular filtration process. In one embodiment, the membrane is formed of polymeric hollow fibers.


One or more membranes may be positioned in one or more membrane modules. The membrane modules may have any shape and cross sectional area suitable for use in a desired application, for example, square, rectangular, or cylindrical. In one embodiment, the membrane modules are rectangular.


According to one embodiment of the invention, one or more membrane modules may be positioned in a second treatment zone in such a way as to be completely submerged by fluid during operation. For example, the membrane module may be positioned vertically, horizontally, or at an angle within the second treatment zone. Multiple membrane modules may be positioned adjacent one another, or located at predetermined positions within the second treatment zone and may, but need not, be positioned in the same plane as others or parallel to one another. In one embodiment, hollow fiber membranes may be positioned horizontally within the second treatment zone. One or more membrane modules may be mounted directly to the vessel or compartment which forms the second treatment zone. Alternatively, one or more membrane modules may be mounted to a module support which may be removably attached to the vessel or compartment forming the second treatment zone. In one embodiment, a plurality of membrane modules are mounted to a module support rack to facilitate membrane maintenance and/or replacement. In another embodiment, membrane modules having vertical partitions may be positioned horizontally.


The second treatment zone may include an aeration system to suspend solids in wastewater or resultant concentrated mixed liquor contained within the second treatment zone, and/or to assist water transfer through the membrane. The aeration system may produce fine bubbles, coarse bubbles, a jet stream of gas, a jet of gas and fluid, and combinations thereof. The aeration system may be positioned in any suitable location within the second treatment zone. In one embodiment, aeration may be provided along a length of one or more membrane modules horizontally positioned.


The wastewater treatment system may comprise an oxygen depletion compartment fluidly connected to the first treatment zone and the second treatment zone. The oxygen depletion compartment may be sized to accept a portion of a wastestream exiting the first treatment zone, as well as a concentrated mixed liquor from the second treatment zone.


According to another embodiment, the wastewater treatment system may comprise one or more pretreatment units, such as to collect solids and/or to remove phosphorous. In one embodiment the pretreatment unit is a trap to remove floating solids, such as grease, and other gross organic solids until they become more soluble, and is positioned upstream of the first treatment zone. The trap may be sized to provide a volume of about 1×FF (1 forward feed or about 5,000 gpd). In another embodiment, the pretreatment unit is a chemical phosphorous removal unit.


According to another embodiment, the wastewater treatment system may comprise an equalization tank and/or a reserve storage tank fluidly connected to the bioreactor. The tank may be sized to accommodate fluctuations in wastewater generation to normalize flow into the bioreactor. For example, the equalization capacity may be equal to about 8 hours or about 33% of the FF. The same tank may also be sized to provide reserve capacity for an emergency such as a power failure, and may have a reserve capacity of about 16 hours or about 67% of the FF. In one embodiment, the tank is sized to provide a volume of about 1×FF (about 5,000 gpd) to provide for equalization and a reserve.


Referring to the figures, FIG. 1 illustrates one embodiment of the present wastewater treatment system. FIG. 1 shows a bioreactor 10 comprising an aerobic compartment 12, an anoxic compartment 14, and an oxygen depletion compartment 16. Two membrane modules 18 are positioned in the aerobic compartment 12. A high level sensor 28 in aerobic compartment 12 indicates that the wastewater in the aerobic compartment is approaching full volume, and may indicate that one or both of the membrane modules are not functioning properly. High level sensor 28 may turn off pump 42 in equalization/reserve tank 40 to interrupt wastewater flow into the bioreactor 10 and sound an alarm. Low level sensor 30 in the aerobic compartment 12 indicates that the level of wastewater in the aerobic compartment may fall below the plane of the membrane modules 18, and may subsequently expose the membranes to air causing them to dry. Low level sensor 30 may close valve 50 on line 36 to interrupt flow of filtrate leaving the bioreactor.


Also as shown in FIG. 1, fluidized media 20 carrying an immobilized denitrifying bacteria is positioned in the anoxic compartment 14 and is prevented from entering the aerobic compartment 12 by screen 22. Wastewater to be treated enters the anoxic compartment 14 through inlet 32 and fluidizes the fluidizable media 20 under anoxic conditions. The wastewater passes up through the fluidized media 20 containing denitrifying organisms and produces a first treated wastewater. As shown in FIG. 2, a portion of the first treated wastewater passes to the aerobic compartment 12 at about 6×FF (about 30,000 gpd). A second portion of the first treated wastewater passes to an oxygen depletion compartment 16 at about 2×FF (about 10,000 gpd).


Blower 26 forces air through a fine bubble or a coarse bubble aeration system 34 in the aerobic compartment 12, providing an air scour for the membrane modules 18 and fluid circulation for the aerobic process. A portion of the first treated wastewater passes through the membranes under hydrostatic pressure at about 1×FF (5,000 gpd) to produce a filtrate and a concentrated mixed liquor. In FIG. 1, two B30R membrane modules available from US Filter are used. The membrane modules may be oriented vertically, horizontally, or at a predetermined angle. The modules may be assembled to a removable rack that can be lifted from the top of the aerobic compartment 12. A filtrate header (not shown) connects one end of the two membrane modules to line 36. The filtrate exits the first compartment 12 through line 36 for further treatment or release.


The concentrated mixed liquor passes to an oxygen depletion compartment 16 at about 5×FF (25,000 gpd). Dissolved oxygen is removed form the concentrated mixed liquor in the oxygen depletion compartment. The concentrated mixed liquor combines with a portion of the first treated wastewater in the oxygen depletion compartment 16 to produce a secondary wastewater. Pump 24 pumps the secondary wastewater at about 7×FF (35,000 gpd) to a distribution manifold at the bottom of the anoxic compartment 14 for further treatment. As shown in FIG. 2, discharge from pump 24 may include a manifold distribution system 37 to provide a more uniform distribution of upward flow of wastewater and secondary wastewater in the anoxic compartment, thereby ensuring the fluidized media remains fluidized. The manifold distribution system may be sized and shaped to provide adequate distribution of fluid flow. In one embodiment, the manifold distribution system comprises 1.5 inch pipes with multiple 0.25 inch holes to provide uniform distribution of the wastewater and secondary wastewater up through the fluidized media.


Also illustrated in FIG. 1 are trap 38 and equalization/reserve storage tank 40. Wastewater to be treated enters trap 38 at about 1×FF (5,000 gpd) where floating solids are trapped, and inert materials and gross organic solids settle. The wastewater then flows from trap 38 to tank 40 by gravity. Tank 40 has a volume of about 1×FF (5,000 gpd) to equalize flow and provide a reserve. Pump 42 moves the wastewater at about 1×FF (5,000 gpd) to the anoxic compartment 14. Pump 42 may be any pump suitable for the capacity of wastewater to be treated. In one embodiment, pump 42 may be a Zoller 5040 Filtered STEP System. Tank 40 includes 3 level sensors/alarms 44, 46, 48. Low level sensor 44 protects the pump from running dry, and high level sensor 46 activate a timer controlling an automatic valve 50 on line 36. Alarm level sensor 48 activates an alarm system to override the timer and open valve 50.


The flow chart of FIG. 2 illustrate one embodiment of forward feed, however, other forward feeds are contemplated. For example, forward feed from the aerobic compartment, to the oxygen depleting compartment may be increased or decreased depending upon the amount of recirculation desired, and the amount of forward feed required to fluidize the media. However, it is preferable that the forward feed from the aerobic compartment to the oxygen depleting compartment not be increased to such an extent that dissolved oxygen enters the anoxic compartment. Similarly, it is preferable that the forward feed from the oxygen depleting compartment not be increased to such an extent to allow dissolved oxygen to enter the anoxic compartment. However, in some instances, the addition of some dissolved oxygen may be expected. With a media in the system, a biofilm may grow on outer and ineteral surface of the media. When the biofilm has grown to a particular thickness, for example, 50 microns, an inner layer of microorganisms may be exposed to an anoxic environment regardless of whether an outer layer of microorganisms is exposed to aerobic conditions, so that denitrification may occur in the inner layer of the biofilm. Minimal addition of dissolved oxygen is contemplated by this invention as long as the dissolved oxygen does not overwhelm the denitrification process.


Having thus described several aspects of at least one embodiment of this invention, it should be apparent to those skilled in the art that the foregoing is merely illustrative and not limiting, having been presented by way of example only. Numerous modification and other embodiments are within the scope of the invention. In particular, although many embodiments presented herein involve specific combinations of method acts or system elements, it should be understood that those acts and those elements may be combined in other ways to accomplish the same objectives.


Further, acts, elements, and features discusses only in connection with one embodiment are not intended to be excluded from a similar role in other embodiments.


It is to be appreciated that various alterations, modifications, and improvements can readily occur to those skilled in the art ant that such alterations, modifications, and improvements are intended to be part of the disclosure and within the spirit and scope of the invention.


Moreover, it should also be appreciated that the invention is directed to each feature, system, subsystem, or technique described herein and any combination of two or more features, systems, subsystems, and/or method, if such features, systems, subsystems, and techniques are not mutually inconsistent, is considered to be within the scope of the invention as embodied in the claims.


Use of ordinal terms such as “first,” “second,” “third,” and the like in the claims to modify a claim element does not by itself connote any priority, precedence, or order of one claimed element over another or the temporal order in which acts of a method are performed, but are used merely as labels to distinguish one claim element having a certain name from another element having a same name (but for use of the ordinal term) to distinguish the claim elements.


Those skilled in the art should appreciate that the parameters and configuration described herein are exemplary and that actual parameters and/or configurations will depend on the specific application in which the systems and techniques of the invention are used. Those skilled in the art should also recognize or be able to ascertain, using no more than routing experimentation, equivalents to the specific embodiments of the invention. It is therefore to be understood that the embodiments described herein are presented by way of example only and that, within the scope of the appended claims and equivalents thereto; the invention my be practice otherwise than as specifically described.

Claims
  • 1. A wastewater treatment system comprising: an anoxic compartment fluidly connected to an aerobic compartment;a source of wastewater fluidly connected to a first inlet of the anoxic compartment;a first fluidizable media comprising bacteria positioned in the anoxic compartment;a membrane module comprising a filter membrane positioned in the aerobic compartment; andan oxygen depleting compartment comprising: an outlet directly fluidly connected to a second inlet of the anoxic compartment;a first inlet directly fluidly connected to an outlet of the aerobic compartment; anda second inlet directly fluidly connected to an outlet of the anoxic compartment.
  • 2. The wastewater treatment system of claim 1, further comprising an equalization tank positioned upstream of the anoxic compartment.
  • 3. The wastewater treatment system of claim 2, further comprising a pretreatment unit positioned upstream of the equalization tank.
  • 4. The wastewater treatment system of claim 3, wherein the pretreatment unit is a trap.
  • 5. The wastewater treatment system of claim 3, wherein the pretreatment unit is a phosphorous removal unit.
  • 6. The wastewater treatment system of claim 1, wherein the membrane module is disposed at an angle in the second treatment zone.
  • 7. The wastewater treatment system of claim 6, wherein the module is disposed horizontally in the second treatment zone.
  • 8. The wastewater treatment system of claim 1, further comprising means for fluidizing the fluidizable media.
  • 9. The wastewater treatment system of claim 8, wherein the means for fluidizing the fluidizable media comprises a manifold positioned in the anoxic compartment below the fluidizable media.
  • 10. The wastewater treatment system of claim 8, further comprising means for maintaining the fluidizable media within the anoxic compartment.
  • 11. The wastewater treatment system of claim 1, wherein the anoxic compartment further comprises a second fluidizable media in a region separate from the first fluidizable media, the second fluidizable media supporting a different organism than the first fluidizable media.
  • 12. The wastewater treatment system of claim 11, wherein the second fluidizable media is different from the first fluidizable media.
  • 13. The wastewater treatment system of claim 1, wherein the bacteria is anoxic bacteria.
  • 14. The wastewater treatment system of claim 13, wherein the bacteria is denitrifying bacteria.
  • 15. The wastewater treatment system of claim 1, further comprising an aeration system in the aerobic compartment.
  • 16. The wastewater treatment system of claim 2, further comprising a level sensor positioned in the aerobic compartment; and a valve positioned in a filtrate exit line of the aerobic compartment, the valve responsive to a signal generated by the level sensor.
RELATED APPLICATIONS

This application is a continuation under 35 U.S.C. §120 of U.S. application Ser. No. 11/542,752, entitled “METHOD AND APPARATUS FOR TREATING WASTEWATER,” filed on Oct. 4, 2006, which claims priority under 35 U.S.C. §119(e) to U.S. Provisional Application Ser. No. 60/723,744, entitled “METHOD AND APPARATUS FOR TREATING WASTEWATER,” filed on Oct. 5, 2005, each of which is herein incorporated by reference in its entirety for all purposes.

US Referenced Citations (408)
Number Name Date Kind
256008 Leak Apr 1882 A
285321 Tams Sep 1883 A
1997074 Novotny Apr 1935 A
2080783 Petersen May 1937 A
2105700 Ramage Jan 1938 A
2843038 Manspeaker Jul 1958 A
2926086 Chenicek et al. Feb 1960 A
3183191 Hach May 1965 A
3198636 Bouthilet Aug 1965 A
3228876 Mahon Jan 1966 A
3442002 Geary et al. May 1969 A
3462362 Kollsman Aug 1969 A
3492698 Geary et al. Feb 1970 A
3556305 Shorr Jan 1971 A
3591010 Pall Jul 1971 A
3625827 Wildi et al. Dec 1971 A
3654147 Levin et al. Apr 1972 A
3693406 Tobin, III Sep 1972 A
3700561 Ziffer Oct 1972 A
3708071 Crowley Jan 1973 A
3728256 Cooper, IV Apr 1973 A
3763055 White et al. Oct 1973 A
3791631 Meyer Feb 1974 A
3804258 Okuniewski et al. Apr 1974 A
3843809 Luck Oct 1974 A
3876738 Marinaccio et al. Apr 1975 A
3955998 Clampitt et al. May 1976 A
3968192 Hoffman, III et al. Jul 1976 A
3992301 Shippey et al. Nov 1976 A
3993816 Baudet et al. Nov 1976 A
4049765 Yamazaki Sep 1977 A
4076656 White et al. Feb 1978 A
4082683 Galesloot Apr 1978 A
4105731 Yamazaki Aug 1978 A
4107043 McKinney Aug 1978 A
4138460 Tigner Feb 1979 A
4183890 Bollinger Jan 1980 A
4188817 Steigelmann Feb 1980 A
4190411 Fujimoto Feb 1980 A
4192750 Elfes et al. Mar 1980 A
4193780 Cotton, Jr. et al. Mar 1980 A
4203848 Grandine, II May 1980 A
4204961 Cusato, Jr. May 1980 A
4218324 Hartmann et al. Aug 1980 A
4226921 Tsang Oct 1980 A
4227295 Bodnar et al. Oct 1980 A
4230583 Chiolle et al. Oct 1980 A
4247498 Castro Jan 1981 A
4248648 Kopp Feb 1981 A
4253936 Leysen et al. Mar 1981 A
4271026 Chen et al. Jun 1981 A
4302336 Kawaguchi et al. Nov 1981 A
4340479 Pall Jul 1982 A
4350592 Kronsbein Sep 1982 A
4353802 Hara et al. Oct 1982 A
4359359 Gerlach et al. Nov 1982 A
4369605 Opersteny et al. Jan 1983 A
4384474 Kowalski May 1983 A
4385150 Miyake et al. May 1983 A
4388189 Kawaguchi et al. Jun 1983 A
4389363 Molthop Jun 1983 A
4407975 Yamaguchi Oct 1983 A
4412003 Evans Oct 1983 A
4414113 LaTerra Nov 1983 A
4414172 Leason Nov 1983 A
4431545 Pall et al. Feb 1984 A
4451369 Sekino et al. May 1984 A
4476112 Aversano Oct 1984 A
4491522 Ishida et al. Jan 1985 A
4496470 Kapiloff et al. Jan 1985 A
4511471 Müller Apr 1985 A
4519909 Castro May 1985 A
4540490 Shibata et al. Sep 1985 A
4547289 Okano et al. Oct 1985 A
4609465 Miller Sep 1986 A
4610789 Barch Sep 1986 A
4614109 Hofmann Sep 1986 A
4623670 Mutoh et al. Nov 1986 A
4629563 Wrasidlo Dec 1986 A
4632745 Giuffrida et al. Dec 1986 A
4636296 Kunz Jan 1987 A
4642182 Drori Feb 1987 A
4647377 Miura Mar 1987 A
4650586 Ellis, III Mar 1987 A
4650596 Schleuter et al. Mar 1987 A
4656865 Callan Apr 1987 A
4660411 Reid Apr 1987 A
4666543 Kawano May 1987 A
4670145 Edwards Jun 1987 A
4673507 Brown Jun 1987 A
4687561 Kunz Aug 1987 A
4687578 Stookey Aug 1987 A
4688511 Gerlach et al. Aug 1987 A
4689191 Beck et al. Aug 1987 A
4702836 Mutoh et al. Oct 1987 A
4702840 Degen et al. Oct 1987 A
4707266 Degen et al. Nov 1987 A
4708799 Gerlach et al. Nov 1987 A
4718270 Storr Jan 1988 A
4744240 Reichelt May 1988 A
4749487 Lefebvre Jun 1988 A
4756875 Tajima et al. Jul 1988 A
4763612 Iwanami Aug 1988 A
4767539 Ford Aug 1988 A
4774132 Joffee et al. Sep 1988 A
4775471 Nagai et al. Oct 1988 A
4779448 Gogins Oct 1988 A
4781831 Goldsmith Nov 1988 A
4784771 Wathen et al. Nov 1988 A
4793932 Ford et al. Dec 1988 A
4797187 Davis et al. Jan 1989 A
4797211 Ehrfeld et al. Jan 1989 A
4810384 Fabre Mar 1989 A
4812235 Seleman et al. Mar 1989 A
4816160 Ford et al. Mar 1989 A
4824563 Iwahori et al. Apr 1989 A
4834998 Shrikhande May 1989 A
4839048 Reed et al. Jun 1989 A
4840227 Schmidt Jun 1989 A
4846970 Bertelsen et al. Jul 1989 A
4867883 Daigger et al. Sep 1989 A
4876006 Ohkubo et al. Oct 1989 A
4876012 Kopp et al. Oct 1989 A
4886601 Iwatsuka et al. Dec 1989 A
4888115 Marinaccio et al. Dec 1989 A
4904426 Lundgard et al. Feb 1990 A
4913819 Patterson Apr 1990 A
4919815 Copa et al. Apr 1990 A
4921610 Ford et al. May 1990 A
4931186 Ford et al. Jun 1990 A
4933084 Bandel et al. Jun 1990 A
4935143 Kopp et al. Jun 1990 A
4963304 Im et al. Oct 1990 A
4968430 Hildenbrand et al. Nov 1990 A
4968733 Muller et al. Nov 1990 A
4969997 Klüver et al. Nov 1990 A
4988444 Applegate et al. Jan 1991 A
4999038 Lundberg Mar 1991 A
5005430 Kibler et al. Apr 1991 A
5015275 Beck et al. May 1991 A
5024762 Ford et al. Jun 1991 A
5034125 Karbachsch et al. Jul 1991 A
5043113 Kafchinski et al. Aug 1991 A
5059317 Marius et al. Oct 1991 A
5066375 Parsi et al. Nov 1991 A
5066401 Müller et al. Nov 1991 A
5066402 Anselme et al. Nov 1991 A
5069065 Sprunt et al. Dec 1991 A
5075065 Effenberger et al. Dec 1991 A
5076925 Roesink et al. Dec 1991 A
5079272 Allegrezza et al. Jan 1992 A
5094750 Kopp et al. Mar 1992 A
5094867 Detering et al. Mar 1992 A
5098567 Nishiguchi Mar 1992 A
5104535 Cote et al. Apr 1992 A
5104546 Filson et al. Apr 1992 A
H1045 Wilson May 1992 H
5135663 Newberth, III et al. Aug 1992 A
5137631 Eckman et al. Aug 1992 A
5138870 Lyssy Aug 1992 A
5147553 Waite Sep 1992 A
5151191 Sunaoka et al. Sep 1992 A
5151193 Grobe et al. Sep 1992 A
5158721 Allegrezza, Jr. et al. Oct 1992 A
5169528 Karbachasch et al. Dec 1992 A
5182019 Cote et al. Jan 1993 A
5192442 Piccirillo et al. Mar 1993 A
5192456 Ishida et al. Mar 1993 A
5192478 Caskey Mar 1993 A
5194149 Selbie et al. Mar 1993 A
5198116 Comstock et al. Mar 1993 A
5198162 Park et al. Mar 1993 A
5209852 Sunaoka et al. May 1993 A
5211823 Giuffrida et al. May 1993 A
5221478 Dhingra et al. Jun 1993 A
5227063 Langerak et al. Jul 1993 A
5248424 Cote et al. Sep 1993 A
5262054 Wheeler Nov 1993 A
5271830 Faivre et al. Dec 1993 A
5275766 Gadkaree et al. Jan 1994 A
5286324 Kawai et al. Feb 1994 A
5290457 Karbachasch et al. Mar 1994 A
5297420 Gilliland et al. Mar 1994 A
5316671 Murphy May 1994 A
5320760 Freund et al. Jun 1994 A
5353630 Soda et al. Oct 1994 A
5358732 Seifter et al. Oct 1994 A
5361625 Ylvisaker Nov 1994 A
5364527 Zimmerman et al. Nov 1994 A
5364529 Morin et al. Nov 1994 A
5374353 Murphy Dec 1994 A
5389260 Hemp et al. Feb 1995 A
5393433 Espenan et al. Feb 1995 A
5396019 Sartori et al. Mar 1995 A
5401401 Hickok et al. Mar 1995 A
5401405 Loker Mar 1995 A
5403479 Smith et al. Apr 1995 A
5405528 Selbie et al. Apr 1995 A
5411663 Johnson May 1995 A
5417101 Weich May 1995 A
5419816 Sampson et al. May 1995 A
5451317 Ishida et al. Sep 1995 A
5458779 Odegaard Oct 1995 A
5468397 Barboza et al. Nov 1995 A
5470469 Eckman Nov 1995 A
5477731 Mouton Dec 1995 A
5479590 Lin Dec 1995 A
5480553 Yamamori et al. Jan 1996 A
5484528 Yagi et al. Jan 1996 A
5490939 Gerigk et al. Feb 1996 A
5491023 Tsai et al. Feb 1996 A
5501798 Al-Samadi et al. Mar 1996 A
5525220 Yagi et al. Jun 1996 A
5531848 Brinda et al. Jul 1996 A
5531900 Raghavan et al. Jul 1996 A
5543002 Brinda et al. Aug 1996 A
5552047 Oshida et al. Sep 1996 A
5554283 Brinda et al. Sep 1996 A
5556591 Jallerat et al. Sep 1996 A
5575963 Soffer et al. Nov 1996 A
5597732 Bryan-Brown Jan 1997 A
5607593 Cote et al. Mar 1997 A
5639373 Mahendran et al. Jun 1997 A
5643455 Kopp et al. Jul 1997 A
5647988 Kawanishi et al. Jul 1997 A
5670053 Collentro et al. Sep 1997 A
5677360 Yamamori et al. Oct 1997 A
5688460 Ruschke Nov 1997 A
5733456 Okey et al. Mar 1998 A
5744037 Fujimura et al. Apr 1998 A
5747605 Breant et al. May 1998 A
5766479 Collentro et al. Jun 1998 A
5783083 Henshaw et al. Jul 1998 A
5843069 Butler et al. Dec 1998 A
5846424 Khudenko Dec 1998 A
5888401 Nguyen Mar 1999 A
5895570 Liang Apr 1999 A
5906739 Osterland et al. May 1999 A
5906742 Wang et al. May 1999 A
5910250 Mahendran et al. Jun 1999 A
5914039 Mahendran et al. Jun 1999 A
5918264 Drummond et al. Jun 1999 A
5942113 Morimura Aug 1999 A
5944997 Pedersen et al. Aug 1999 A
5951878 Astrom Sep 1999 A
5958243 Lawrence et al. Sep 1999 A
5961830 Barnett Oct 1999 A
5968357 Doelle et al. Oct 1999 A
5988400 Karachevtcev et al. Nov 1999 A
5997745 Tonelli et al. Dec 1999 A
6017451 Kopf Jan 2000 A
6024872 Mahendran Feb 2000 A
6036030 Stone et al. Mar 2000 A
6039872 Wu et al. Mar 2000 A
6042677 Mahendran et al. Mar 2000 A
6045698 Cöté et al. Apr 2000 A
6045899 Wang et al. Apr 2000 A
6048454 Jenkins Apr 2000 A
6048455 Janik Apr 2000 A
6066401 Stilburn May 2000 A
6074718 Puglia et al. Jun 2000 A
6077435 Beck et al. Jun 2000 A
6083393 Wu et al. Jul 2000 A
6096213 Radovanovic et al. Aug 2000 A
6113782 Leonard Sep 2000 A
6120688 Daly et al. Sep 2000 A
6126819 Heine et al. Oct 2000 A
6146747 Wang et al. Nov 2000 A
6149817 Peterson et al. Nov 2000 A
6156200 Zha et al. Dec 2000 A
6159373 Beck et al. Dec 2000 A
6193890 Pedersen et al. Feb 2001 B1
6202475 Selbie et al. Mar 2001 B1
6214231 Cote et al. Apr 2001 B1
6214232 Baurmeister et al. Apr 2001 B1
6221247 Nemser et al. Apr 2001 B1
6245239 Cote et al. Jun 2001 B1
6254773 Biltoft Jul 2001 B1
6264839 Mohr et al. Jul 2001 B1
6277512 Hamrock et al. Aug 2001 B1
6280626 Miyashita et al. Aug 2001 B1
6284135 Ookata Sep 2001 B1
6290756 Macheras et al. Sep 2001 B1
6294039 Mahendran et al. Sep 2001 B1
6299773 Takamura et al. Oct 2001 B1
6303026 Lindbo Oct 2001 B1
6303035 Cote et al. Oct 2001 B1
6315895 Summerton et al. Nov 2001 B1
6322703 Taniguchi et al. Nov 2001 B1
6325928 Pedersen et al. Dec 2001 B1
6337018 Mickols Jan 2002 B1
RE37549 Mahendran et al. Feb 2002 E
6354444 Mahendran Mar 2002 B1
6361695 Husain et al. Mar 2002 B1
6368819 Gaddy et al. Apr 2002 B1
6372138 Cho et al. Apr 2002 B1
6375848 Cote et al. Apr 2002 B1
6387189 Gröschl et al. May 2002 B1
6402955 Ookata Jun 2002 B2
6406629 Husain et al. Jun 2002 B1
6423214 Lindbo Jul 2002 B1
6423784 Hamrock et al. Jul 2002 B1
6432310 Andou et al. Aug 2002 B1
6440303 Spriegel Aug 2002 B2
D462699 Johnson et al. Sep 2002 S
6444124 Onyeche et al. Sep 2002 B1
6468430 Kimura et al. Oct 2002 B1
6485645 Husain et al. Nov 2002 B1
6495041 Taniguchi et al. Dec 2002 B2
6524481 Zha et al. Feb 2003 B2
6524733 Nonobe Feb 2003 B1
6550747 Rabie et al. Apr 2003 B2
6555005 Zha et al. Apr 2003 B1
6576136 De Moel et al. Jun 2003 B1
D478913 Johnson et al. Aug 2003 S
6620319 Behmann et al. Sep 2003 B2
6627082 Del Vecchio Sep 2003 B2
6635179 Summerton et al. Oct 2003 B1
6641733 Zha et al. Nov 2003 B2
6645374 Cote et al. Nov 2003 B2
6656356 Gungerich et al. Dec 2003 B2
6682652 Mahendran et al. Jan 2004 B2
6685832 Mahendran et al. Feb 2004 B2
6696465 Dellaria et al. Feb 2004 B2
6702561 Stillig et al. Mar 2004 B2
6706189 Rabie et al. Mar 2004 B2
6708957 Cote et al. Mar 2004 B2
6721529 Chen et al. Apr 2004 B2
6723758 Stone et al. Apr 2004 B2
6727305 Pavez Aranguiz Apr 2004 B1
6743362 Porteous et al. Jun 2004 B1
6758972 Vriens et al. Jul 2004 B2
6770202 Kidd et al. Aug 2004 B1
6780466 Grangeon et al. Aug 2004 B2
6783008 Zha et al. Aug 2004 B2
6790912 Blong Sep 2004 B2
6805806 Arnaud Oct 2004 B2
6811696 Wang et al. Nov 2004 B2
6814861 Husain et al. Nov 2004 B2
6821420 Zha et al. Nov 2004 B2
6841070 Zha et al. Jan 2005 B2
6861466 Dadalas et al. Mar 2005 B2
6863817 Liu et al. Mar 2005 B2
6863818 Daigger et al. Mar 2005 B2
6863823 Côté Mar 2005 B2
6869534 McDowell et al. Mar 2005 B2
6872305 Johnson et al. Mar 2005 B2
6881343 Rabie et al. Apr 2005 B2
6884350 Muller Apr 2005 B2
6884375 Wang et al. Apr 2005 B2
6890435 Ji et al. May 2005 B2
6890645 Disse et al. May 2005 B2
6893568 Janson et al. May 2005 B1
6899812 Cote et al. May 2005 B2
6946073 Daigger et al. Sep 2005 B2
6952258 Ebert et al. Oct 2005 B2
6955762 Gallagher et al. Oct 2005 B2
6962258 Zha et al. Nov 2005 B2
6964741 Mahendran et al. Nov 2005 B2
7147778 DiMassimo et al. Dec 2006 B1
7160455 Taniguchi et al. Jan 2007 B2
7160463 Beck et al. Jan 2007 B2
7172701 Gaid et al. Feb 2007 B2
7223340 Zha et al. May 2007 B2
7226541 Muller et al. Jun 2007 B2
7247238 Mullette et al. Jul 2007 B2
7264716 Johnson et al. Sep 2007 B2
7300022 Muller Nov 2007 B2
7387723 Jordan Jun 2008 B2
7455765 Elefritz et al. Nov 2008 B2
7476322 Dimitriou et al. Jan 2009 B2
20020070157 Yamada Jun 2002 A1
20020148767 Johnson et al. Oct 2002 A1
20030038080 Vriens et al. Feb 2003 A1
20030057155 Husain et al. Mar 2003 A1
20030127388 Ando et al. Jul 2003 A1
20030146153 Cote et al. Aug 2003 A1
20030150807 Bartels et al. Aug 2003 A1
20030178365 Zha et al. Sep 2003 A1
20030226797 Phelps Dec 2003 A1
20040007525 Rabie et al. Jan 2004 A1
20040035770 Edwards et al. Feb 2004 A1
20040084369 Zha et al. May 2004 A1
20040145076 Zha et al. Jul 2004 A1
20040168979 Zha et al. Sep 2004 A1
20040178154 Zha et al. Sep 2004 A1
20040217053 Zha et al. Nov 2004 A1
20040232076 Zha et al. Nov 2004 A1
20050029174 Collins Feb 2005 A1
20050029185 Muller Feb 2005 A1
20050029186 Muller Feb 2005 A1
20050032982 Muller et al. Feb 2005 A1
20050103722 Freydina et al. May 2005 A1
20050115880 Pollock Jun 2005 A1
20050115899 Liu et al. Jun 2005 A1
20050139538 Lazaredes Jun 2005 A1
20050194310 Liu et al. Jun 2005 A1
20050194315 Adams et al. Sep 2005 A1
20060000775 Zha et al. Jan 2006 A1
20060131234 Zha et al. Jun 2006 A1
20060201876 Jordan Sep 2006 A1
20060261007 Zha et al. Nov 2006 A1
20060273038 Syed et al. Dec 2006 A1
20070007214 Zha et al. Jan 2007 A1
20070056905 Beck et al. Mar 2007 A1
20070075021 Johnson Apr 2007 A1
20070108125 Cho et al. May 2007 A1
20070227973 Zha et al. Oct 2007 A1
Foreign Referenced Citations (192)
Number Date Country
3440084 Sep 1983 AU
5584786 Mar 1985 AU
7706687 Jul 1986 AU
1050770 Jan 1995 CN
3904544 Aug 1990 DE
4117281 Jan 1992 DE
4113420 Oct 1992 DE
4117422 Nov 1992 DE
29804927 Jun 1998 DE
29906389 Jun 1999 DE
012557 Feb 1983 EP
126714 Nov 1984 EP
050447 Oct 1985 EP
250337 Dec 1987 EP
327025 Aug 1989 EP
090383 May 1990 EP
407900 Jan 1991 EP
463627 Jan 1992 EP
492942 Jul 1992 EP
518250 Dec 1992 EP
547575 Jun 1993 EP
395133 Feb 1995 EP
492446 Nov 1995 EP
430082 Jun 1996 EP
734758 Oct 1996 EP
763758 Mar 1997 EP
824956 Feb 1998 EP
855214 Jul 1998 EP
627255 Jan 1999 EP
911073 Apr 1999 EP
920904 Jun 1999 EP
1034835 Sep 2000 EP
1052012 Nov 2000 EP
1349644 Oct 2003 EP
1350555 Oct 2003 EP
1236503 Aug 2004 EP
2620712 Mar 1989 FR
2674448 Oct 1992 FR
2699424 Jun 1994 FR
702911 Jan 1954 GB
2253572 Sep 1992 GB
54-162684 Dec 1979 JP
55-129155 Jun 1980 JP
55-099703 Jul 1980 JP
55-129107 Oct 1980 JP
56-021604 Feb 1981 JP
56-118701 Sep 1981 JP
56-121685 Sep 1981 JP
58-088007 May 1983 JP
60-019002 Jan 1985 JP
60-206412 Oct 1985 JP
61-097005 May 1986 JP
61-097006 May 1986 JP
61-107905 May 1986 JP
61-167406 Jul 1986 JP
61-167407 Jul 1986 JP
61-171504 Aug 1986 JP
61-192309 Aug 1986 JP
61-222510 Oct 1986 JP
61-242607 Oct 1986 JP
61-249505 Nov 1986 JP
61-257203 Nov 1986 JP
61-263605 Nov 1986 JP
61-291007 Dec 1986 JP
61-293504 Dec 1986 JP
62-004408 Jan 1987 JP
62-114609 May 1987 JP
62-140607 Jun 1987 JP
62-144708 Jun 1987 JP
62-163708 Jul 1987 JP
62-179540 Aug 1987 JP
62-250908 Oct 1987 JP
63-097634 Apr 1988 JP
63-143905 Jun 1988 JP
63-171607 Jul 1988 JP
63-180254 Jul 1988 JP
S63-38884 Oct 1988 JP
01-151906 Jun 1989 JP
01-307409 Dec 1989 JP
02-026625 Jan 1990 JP
02-031200 Feb 1990 JP
02-107318 Apr 1990 JP
02-126922 May 1990 JP
02-144132 Jun 1990 JP
02-164423 Jun 1990 JP
02-277528 Nov 1990 JP
02-284035 Nov 1990 JP
03-018373 Jan 1991 JP
03-028797 Feb 1991 JP
03-110445 May 1991 JP
04-187224 Jul 1992 JP
04-250898 Sep 1992 JP
04-256424 Sep 1992 JP
04-265128 Sep 1992 JP
04-293527 Oct 1992 JP
04-310223 Nov 1992 JP
04-348252 Dec 1992 JP
05-023557 Feb 1993 JP
05-096136 Apr 1993 JP
05-137977 Jun 1993 JP
05-157654 Jun 1993 JP
05-285348 Nov 1993 JP
06-071120 Mar 1994 JP
06-114240 Apr 1994 JP
06-218237 Aug 1994 JP
06-277469 Oct 1994 JP
06-285496 Oct 1994 JP
06-343837 Dec 1994 JP
07-000770 Jan 1995 JP
07-024272 Jan 1995 JP
07-068139 Mar 1995 JP
07-136470 May 1995 JP
07-136471 May 1995 JP
07-155758 Jun 1995 JP
07-178323 Jul 1995 JP
07-185268 Jul 1995 JP
07-185271 Jul 1995 JP
07-236819 Sep 1995 JP
07-251043 Oct 1995 JP
07-275665 Oct 1995 JP
07-289860 Nov 1995 JP
07-303895 Nov 1995 JP
08-010585 Jan 1996 JP
09-099227 Apr 1997 JP
09-141063 Jun 1997 JP
09-187628 Jul 1997 JP
09-220569 Aug 1997 JP
09-271641 Oct 1997 JP
09-324067 Dec 1997 JP
10-033955 Feb 1998 JP
10-048466 Feb 1998 JP
10-085565 Apr 1998 JP
10-156149 Jun 1998 JP
11-028467 Feb 1999 JP
11-156166 Jun 1999 JP
11-165200 Jun 1999 JP
11-333265 Jul 1999 JP
11-033365 Sep 1999 JP
11-319507 Nov 1999 JP
2000-070684 Mar 2000 JP
2000-185220 Apr 2000 JP
2000-157850 Jun 2000 JP
2000-317276 Nov 2000 JP
2001-009246 Jan 2001 JP
2001-070967 Mar 2001 JP
2001-079367 Mar 2001 JP
2001-104760 Apr 2001 JP
2001-190937 Jul 2001 JP
2001-190938 Jul 2001 JP
2001-205055 Jul 2001 JP
2000-342932 Dec 2002 JP
2003-047830 Feb 2003 JP
2003-062436 Mar 2003 JP
2003-135935 May 2003 JP
2002-0090967 Dec 2002 KR
1020491 Oct 2003 NL
1021197 Oct 2003 NL
347343 Dec 1998 TW
WO 88-06200 Aug 1988 WO
WO 89-00880 Feb 1989 WO
WO 90-00434 Jan 1990 WO
WO 91-04783 Apr 1991 WO
WO 91-16124 Oct 1991 WO
WO 93-02779 Feb 1993 WO
WO 93-15827 Aug 1993 WO
WO 93-23152 Nov 1993 WO
WO 94-11094 May 1994 WO
WO 95-34424 Dec 1995 WO
WO 96-07470 Mar 1996 WO
WO 96-28236 Sep 1996 WO
WO 96-41676 Dec 1996 WO
WO 97-06880 Feb 1997 WO
WO 98-22204 May 1998 WO
WO 98-25694 Jun 1998 WO
WO 98-28066 Jul 1998 WO
WO 98-53902 Dec 1998 WO
WO 99-01207 Jan 1999 WO
WO 99-59707 Nov 1999 WO
WO 00-18498 Apr 2000 WO
WO 00-30742 Jun 2000 WO
WO 01-00307 Jan 2001 WO
WO 01-32299 May 2001 WO
WO 01-36075 May 2001 WO
WO 01-45829 Jun 2001 WO
WO 02-40140 May 2002 WO
WO 03-000389 Jan 2003 WO
WO 03-013706 Feb 2003 WO
WO 2004-101120 Nov 2004 WO
WO 2005-021140 Mar 2005 WO
WO 2005-037414 Apr 2005 WO
WO 2005-077499 Aug 2005 WO
WO 2006-029456 Mar 2006 WO
Related Publications (1)
Number Date Country
20090026120 A1 Jan 2009 US
Provisional Applications (1)
Number Date Country
60723744 Oct 2005 US
Continuations (1)
Number Date Country
Parent 11542752 Oct 2006 US
Child 12233195 US